Acrivon Therapeutics, Inc. (ACRV) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-2.02 | +15.1% |
| 2024 | $-2.38 | +13.1% |
| 2023 | $-2.74 | +63.8% |
| 2022 | $-7.56 | +18.9% |
| 2021 | $-9.32 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-2.02 | +15.1% |
| 2024 | $-2.38 | +13.1% |
| 2023 | $-2.74 | +63.8% |
| 2022 | $-7.56 | +18.9% |
| 2021 | $-9.32 | — |